| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.47 | 0.0007 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.17 | 0.001 |